ScoreWhy is ACADIA Pharmaceuticals, Inc. ?
1
Poor Management Efficiency with a low ROE of 5.98%
- The company has been able to generate a Return on Equity (avg) of 5.98% signifying low profitability per unit of shareholders funds
2
Flat results in Mar 26
- DEBT-EQUITY RATIO (HY) Highest at -64.15 %
- DEBTORS TURNOVER RATIO(HY) Lowest at 8.36 times
- OPERATING PROFIT(Q) Lowest at USD -1.62 MM
3
With ROE of 31.86%, it has a very attractive valuation with a 2.88 Price to Book Value
- Over the past year, while the stock has generated a return of -2.06%, its profits have risen by 72.7% ; the PEG ratio of the company is 0.1
4
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Below par performance in long term as well as near term
- Along with generating -2.06% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to ACADIA Pharmaceuticals, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is ACADIA Pharmaceuticals, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
ACADIA Pharmaceuticals, Inc.
-4.28%
1.24
37.80%
S&P 500
22.99%
1.78
12.93%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
19.39%
EBIT Growth (5y)
20.86%
EBIT to Interest (avg)
-91.06
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.88
Sales to Capital Employed (avg)
1.41
Tax Ratio
13.58%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
18.60%
ROE (avg)
5.98%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
2.88
EV to EBIT
26.04
EV to EBITDA
23.42
EV to Capital Employed
6.51
EV to Sales
2.55
PEG Ratio
0.13
Dividend Yield
NA
ROCE (Latest)
24.99%
ROE (Latest)
31.86%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
NET PROFIT(HY)
Higher at USD 277.2 MM
ROCE(HY)
Highest at 37.32%
RAW MATERIAL COST(Y)
Fallen by 0.99% (YoY
CASH AND EQV(HY)
Highest at USD 1,671.14 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 3.43 times
-13What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at -64.15 %
DEBTORS TURNOVER RATIO(HY)
Lowest at 8.36 times
OPERATING PROFIT(Q)
Lowest at USD -1.62 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -0.61 %
PRE-TAX PROFIT(Q)
Lowest at USD 3.98 MM
NET PROFIT(Q)
Lowest at USD 3.64 MM
EPS(Q)
Lowest at USD 0.02
Here's what is working for ACADIA Pharmaceuticals, Inc.
Cash and Eqv
Highest at USD 1,671.14 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 3.43 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by 0.99% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 2.99 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for ACADIA Pharmaceuticals, Inc.
Pre-Tax Profit
At USD 3.98 MM has Fallen at -88.54%
over average net sales of the previous four periods of USD 34.73 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD 3.64 MM has Fallen at -96.28%
over average net sales of the previous four periods of USD 97.75 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Profit
Lowest at USD -1.62 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Operating Profit Margin
Lowest at -0.61 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at USD 3.98 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD 3.64 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
EPS
Lowest at USD 0.02
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
Debt-Equity Ratio
Highest at -64.15 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio
Lowest at 8.36 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Non Operating Income
Highest at USD 2.16 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
